Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,835	11,112	12,824	20,078	28,796	20,702
Market Cap Growth	-5.50%	-13.35%	-36.13%	-30.28%	39.10%	126.07%
Enterprise Value	9,756	9,530	10,935	17,327	25,931	18,996
Last Close Price	34.86	34.67	39.39	61.04	86.98	62.29
PE Ratio	43.00	30.31	31.58	33.42	34.08	54.34
Forward PE	25.20	17.53	18.53	25.87	39.80	50.27
PS Ratio	4.79	4.87	5.62	7.01	13.55	14.77
PB Ratio	2.36	2.41	2.89	4.84	7.91	7.44
P/TBV Ratio	3.38	3.46	3.98	6.17	9.42	9.25
P/FCF Ratio	77.25	67.36	177.91	59.37	74.39	34.07
P/OCF Ratio	41.62	38.10	51.45	31.75	48.66	29.72
EV/Sales Ratio	4.31	4.17	4.79	6.05	12.20	13.55
EV/EBITDA Ratio	32.68	23.17	26.63	27.65	52.80	58.29
EV/EBIT Ratio	53.01	31.08	34.94	30.69	58.67	62.69
EV/FCF Ratio	69.56	57.77	151.70	51.24	66.99	31.26
Debt / Equity Ratio	0.00	0.01	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	0.06	0.06	0.04	0.04	0.01	0.08
Debt / FCF Ratio	0.12	0.14	0.25	0.08	0.02	0.04
Asset Turnover	0.40	0.40	0.41	0.55	0.48	0.40
Inventory Turnover	4.23	4.09	4.53	4.84	3.58	3.93
Quick Ratio	1.96	2.09	2.27	2.68	2.69	2.36
Current Ratio	2.75	2.59	2.69	2.95	3.02	2.62
Return on Equity (ROE)	5.79%	8.41%	9.60%	15.72%	26.44%	14.65%
Return on Assets (ROA)	2.04%	3.39%	3.55%	6.79%	6.25%	5.42%
Return on Invested Capital (ROIC)	5.63%	10.76%	15.88%	52.76%	60.40%	71.48%
Return on Capital Employed (ROCE)	3.90%	6.40%	6.80%	13.10%	11.80%	10.50%
Earnings Yield	2.36%	3.30%	3.17%	2.99%	2.94%	1.84%
FCF Yield	1.29%	1.49%	0.56%	1.68%	1.34%	2.94%
Dividend Yield	1.35%	1.36%	1.31%	0.74%	0.57%	0.61%
Payout Ratio	57.46%	44.48%	35.16%	27.04%	14.30%	14.98%
Buyback Yield / Dilution	0.35%	0.37%	0.20%	-0.06%	2.43%	-30.55%
Total Shareholder Return	1.73%	1.73%	1.51%	0.68%	3.01%	-29.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.